Antimicrobial Dispensing Practice in Community Pharmacies in Russia during the COVID-19 Pandemic

被引:6
|
作者
Rachina, Svetlana [1 ]
Kozlov, Roman [2 ]
Kurkova, Anastasiya [2 ]
Portnyagina, Ulyana [3 ]
Palyutin, Shamil [4 ]
Khokhlov, Aleksandr [4 ]
Reshetko, Olga [5 ]
Zhuravleva, Marina [6 ]
Palagin, Ivan [2 ]
机构
[1] First Moscow State Med Univ, Internal Med Dept 2, Moscow 119991, Russia
[2] Smolensk State Med Univ, Inst Antimicrobial Chemotherapy, Smolensk 214019, Russia
[3] North Eastern Fed Univ, Dept Internal Med & Gen Med Practice, Yakutsk 677007, Russia
[4] Yaroslavl State Med Univ, Dept Clin Pharmacol & Drug Eth, UNESCO, Yaroslavl 150000, Russia
[5] Saratov State Med Univ VI Razumovsky, Dept Pharmacol, Saratov 410012, Russia
[6] First Moscow State Med Univ, Dept Pharmacol & Propedeut Internal Dis, Moscow 119991, Russia
来源
ANTIBIOTICS-BASEL | 2022年 / 11卷 / 05期
关键词
antimicrobials supply; antibiotics; antivirals; COVID-19; community pharmacies;
D O I
10.3390/antibiotics11050586
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
COVID-19 has had a significant impact on health care systems, including drug use. The present study aimed to evaluate the patterns of community supply of antimicrobials from community pharmacies during the COVID-19 pandemic in five cities of Russia. In a cross-sectional study, a random sample of pharmacies reported all episodes of antimicrobials supply during a one-week period. Patterns of supply (age and gender of customer, drug name and formulation, prescription availability, indication, etc.) were analyzed. Altogether, 71 pharmacies took part in the study and 5270 encounters were recorded. In total, 4.2% of visits resulted in supply of more than one antimicrobial agent and 5.2% were for parenteral formulations. The rate of prescription-based purchase in participated cities varied from 40.5 to 99.1%. Systemic antibiotics and antivirals accounted for the majority of supplies (60.5 and 26.3%, respectively). Upper respiratory tract infections were reported as the indication for antimicrobials usage in 36.9% of cases, followed by skin and soft tissue infections (12.1%) and urinary tract infections (8.7%); COVID-19 accounted for 8.4% of all supplies. Amoxicillin with clavulanic acid, azithromycin and amoxicillin were indicated as the top three antimicrobials purchased for upper respiratory tract infections, and azithromycin, umifenovir and levofloxacin were the top three for COVID-19. In general, a high rate of drugs dispensing without prescription was revealed. Antibiotics for systemic use remained the most common antimicrobials, whereas presumably viral upper respiratory tract infections were the main reason for their purchase. COVID-19 infection itself was responsible for a small proportion of the supply of antimicrobial agents, but systemic antibiotics accounted for more than a half of supplies.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Ophthalmology practice during the COVID-19 pandemic
    Safadi, Khaled
    Kruger, Joshua M.
    Chowers, Itay
    Solomon, Abraham
    Amer, Radgonde
    Aweidah, Hamzah
    Frenkel, Shahar
    Mechoulam, Hadas
    Anteby, Irene
    Ben Eli, Hadas
    Lavy, Itay
    Jaouni, Tarek
    Landau, David
    Tiosano, Liran
    Greifner, Gabriel
    Ofir, Shay
    Vineberg, Tamar Levi
    Levy, Jaime
    BMJ OPEN OPHTHALMOLOGY, 2020, 5 (01):
  • [22] Practice Management During the COVID-19 Pandemic
    Vaccaro, Alexander R.
    Getz, Charles L.
    Cohen, Bruce E.
    Cole, Brian J.
    Donnally, Chester J.
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2020, 28 (11) : 464 - 470
  • [23] Perception of COVID-19 During the 2020 Pandemic in Russia
    Pervichko, Elena, I
    Mitina, Olga, V
    Stepanova, Olga B.
    Koniukhovskaia, Julia E.
    Dorokhov, Egor A.
    CLINICAL PSYCHOLOGY AND SPECIAL EDUCATION, 2020, 9 (02): : 119 - 146
  • [24] Somatic burden in Russia during the COVID-19 pandemic
    Zolotareva, Alena
    Khegay, Anna
    Voevodina, Elena
    Kritsky, Igor
    Ibragimov, Roman
    Nizovskih, Nina
    Konstantinov, Vsevolod
    Malenova, Arina
    Belasheva, Irina
    Khodyreva, Natalia
    Preobrazhensky, Vladimir
    Azanova, Kristina
    Sarapultseva, Lilia
    Galimova, Almira
    Atamanova, Inna
    Kulik, Anastasia
    Neyaskina, Yulia
    Lapshin, Maksim
    Mamonova, Marina
    Kadyrov, Ruslan
    Volkova, Ekaterina
    Drachkova, Viktoria
    Seryy, Andrey
    Kosheleva, Natalia
    Osin, Evgeny
    PLOS BIOLOGY, 2023, 21 (03)
  • [25] Somatic burden in Russia during the COVID-19 pandemic
    Zolotareva, Alena
    Khegay, Anna
    Voevodina, Elena
    Kritsky, Igor
    Ibragimov, Roman
    Nizovskih, Nina
    Konstantinov, Vsevolod
    Malenova, Arina
    Belasheva, Irina
    Khodyreva, Natalia
    Preobrazhensky, Vladimir
    Azanova, Kristina
    Sarapultseva, Lilia
    Galimova, Almira
    Atamanova, Inna
    Kulik, Anastasia
    Neyaskina, Yulia
    Lapshin, Maksim
    Mamonova, Marina
    Kadyrov, Ruslan
    Volkova, Ekaterina
    Drachkova, Viktoria
    Seryy, Andrey
    Kosheleva, Natalia
    Osin, Evgeny
    PLOS ONE, 2023, 18 (03):
  • [26] Health behavior in Russia during the COVID-19 pandemic
    Peshkovskaya, Anastasia
    Galkin, Stanislav
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [27] Urology practice during the COVID-19 pandemic
    Ficarra, Vincenzo
    Novara, Giacomo
    Abrate, Alberto
    Bartoletti, Riccardo
    Crestani, Alessandro
    De Nunzio, Cosimo
    Giannarini, Gianluca
    Gregori, Andrea
    Liguori, Giovanni
    Mirone, Vincenzo
    Pavan, Nicola
    Scarpa, Roberto M.
    Simonato, Alchiede
    Trombetta, Carlo
    Tubaro, Andrea
    Porpiglia, Francesco
    MINERVA UROLOGICA E NEFROLOGICA, 2020, 72 (03) : 369 - 375
  • [29] Crisis management in Finnish hospital pharmacies during the COVID-19 pandemic
    Latonen, S.
    Juppo, A. M.
    Seeck, H.
    Airaksinen, M.
    BMC HEALTH SERVICES RESEARCH, 2025, 25 (01)
  • [30] Utilization of telemedicine and antibiotic dispensing before and during the COVID-19 pandemic
    Tran, Phuong T.
    Goodin, Amie
    Happe, Laura
    Daniels, Michael
    Winterstein, Almut G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 207 - 207